-
Two-dose COVID-19 vaccine response works against delta variant, researchers find
firstwordpharma
July 09, 2021
New data out of France adds to evidence that widely used COVID-19 vaccines still offer strong protection against the Delta variant, which is spreading around the world and is now the most prevalent strain in the US, as reported by CBC News.
-
U.S. to send 500,000 Pfizer COVID-19 vaccine doses to Uruguay
firstwordpharma
July 09, 2021
The United States will send 500,000 doses of Pfizer’s COVID-19 vaccine to Uruguay on Thursday, the White House said, as reported by the National Post.
-
Study Confirms That Black People Are at Higher Risk for COVID-19, and Reveals That Affluent Whites Are Also at High Risk
prnewswire
July 09, 2021
Breaking research published in AACC's The Journal of Applied Laboratory Medicine has found that, at the start of the pandemic, the two demographic groups most likely to get COVID-19 were low socioeconomic status Black people and high socioeconomic status.
-
Phage Display-Based Gene Delivery: A Viable Platform Technology for COVID-19 Vaccine Design and Development
firstwordpharma
July 08, 2021
Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19.
-
Vaccine Stocks Skid As Delta Variant Becomes More Prevalent U.S. Covid Strain
firstwordpharma
July 08, 2021
Stocks of COVID-19 vaccine developers skidded on Wednesday after the US Centers for Disease Control and Prevention (CDC) indicated that the highly transmissible Delta variant makes up close to 52% of cases in the country, reported Investor's Business Dail
-
Huons acquires marketing rights for Sputnik Light in S. Korea
firstwordpharma
July 08, 2021
Huons Global has secured marketing rights for Russia's COVID-19 vaccine Sputnik Light in South Korea, said The Korea Herald.
-
COVID Vaccine Doesn't Infiltrate Breast Milk
drugs
July 07, 2021
Women who are breastfeeding and wonder if COVID-19 vaccination is safe for their baby may be reassured by the results of a new study.
-
Recipharm selected to operate new fill/finish facility in Morocco
cphi-online
July 07, 2021
Move is part of US$500 million five-year investment programme by Moroccan government and consortium to establish vaccine and biotherapeutic manufacturing capacity in the country
-
Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate
prnewswire
July 07, 2021
Dynavax Technologies Corporation today announced the execution of a commercial supply agreement of Dynavax's CpG 1018TM advanced adjuvant, for use in BE's subunit COVID-19 vaccine candidate, CORBEVAX™.
-
Researchers find potential path to a broadly protective COVID-19 vaccine using T cells
firstwordpharma
July 06, 2021
Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind.